A novel agent for myeloma causing toxic keratopathy, belantamab mafodotin: a case report and literature review

Rengin Aslıhan Kurt¹; Deniz Gören²; Sehnaz Karadeniz³; Mutlu Arat²; Afsun Sahin⁴

DOI: 10.5935/0004-2749.2021-0358

1. Department of Ophthalmology, Baskent University Istanbul Hospital, Istanbul, Turkey
2. Department of Hematology, Sisli Florence Nightingale Hospital, Istanbul, Turkey
3. Department of Ophthalmology, Sisli Florence Nightingale Hospital, Istanbul, Turkey
4. Department of Ophthalmology, Koc University Medical School, Istanbul, Turkey

Corresponding author

Rengin Aslıhan Kurt
E-mail: renginakurt@yahoo.com

PDF English Print

How to cite this article:

Kurt RA, Gören D, Karadeniz S, Arat M, Sahin A. Belantamabe-mafodotina, um novo agente para mieloma, causando ceratopatia tóxica: relato de caso e revisão da literatura. Arq. Bras. Oftalmol. 2024;87(4):. 10.5935/0004-2749.2021-0358

Export citation